Calviri has been developing an RNA vaccine to prevent cancer for more than 20 years and repeatedly faced the nearly universal belief that it’s impossible. We’ve learned a number of important lessons along the way that are worth imparting to other vaccine developers.
- 6 PEG Alternatives You Should Be Thinking About
- Achieving Flexibility In RNA Drug Manufacturing With Microfluidics
- Modular And Single-use Tech Driving The Future Of Biomanufacturing
- What We Need To Unlock Next-Generation mRNA Therapeutics
- What Regenerative Medicine Manufacturers Have Been Waiting For
- New Developments In mRNA Vaccine Efficacy Show Promise
- FDA Sets Recommendations For Predicting Dangerous Nitrosamine Impurities
- Oh, Oligonucleotides! Everybody Wants In
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
Moving CGTx Clinical Development Forward In 2023
Gain insights on cell and gene therapy (CGTx) clinical trial design and commercialization strategies as a panel of industry experts share their considerations.
Leveraging Single-Use Technology For mRNA-LNP Drug Manufacturing
Single-use technology is vital for ensuring the quality and expedited market entry of genomic medicines. Learn how LNP technology is paving the way for a new era of personalized, precise medicine.
RNA: The Next Era In Therapeutic Development
Review the unique set of challenges for RNA production that must be considered and solved to reach their full therapeutic potential.
RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific
Learn about the global clinical trial landscape of RNA therapy, with emphasis on trends in the Asia Pacific, and recent advancements in the field.
Fit-For-Purpose Lipids Can Accelerate, Scale, And Improve RNA-LNP Drugs
Emerging biotech companies are investing in novel delivery capabilities to address different modalities' needs and extra-hepatic delivery. Explore steps to accelerate commercial nanomedicine delivery.
mRNA Product IVT Process Insights
In vitro transcription (IVT) allows a researcher to tailor synthesis and introduce modifications to produce a transcript. Learn about IVT along with process challenges and strategies.
mRNA: How To Build A Custom Program Using CDMO Services
Development of RNA-based therapies sits at the cutting edge of vaccine and oncology innovation, in addition to holding promise in dozens of other therapeutic areas.
Purification Of DNA Oligonucleotides Using An Anion Exchange Resin
Learn how a strong anion exchange resin can be used for the efficient purification of single-stranded DNA oligonucleotides used in clinical trials.
mRNA-LNP Nucleic Acid Assessment From Distinct Formulations
Review a showcase of a high throughput robust analysis for nucleic acid integrity and size assessment of mRNA-LNP samples using a multi-capillary system and purity and integrity analysis kit.
Determining RNA Integrity And Purity By Capillary Gel Electrophoresis
To ensure mRNA product quality, it's important to confirm the integrity of the RNA. Examine the results of a study challenging the performance of the CGE method in assessing mRNA integrity and purity.